Paper20157366
Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.
Al-Salami H and 5 others. Arch Drug Inf, 2008. Cited by 48 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats. Papers, record 20157366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20157366
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12,554,153 | A simple and sensitive HPLC method for determination of gliclazide in human serum. | J Chromatogr B Analyt Technol Biomed Life Sci | 2003 | https://conductscience.org/library/papers/12554153 | PubMed |
| 2 | 10,767,599 | Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: importance of drug ionisation in the in vitro prediction of in vivo absorption. | Eur J Pharm Sci | 2000 | https://conductscience.org/library/papers/10767599 | PubMed |
| 3 | 9,721,312 | Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains. | J Bacteriol | 1998 | https://conductscience.org/library/papers/9721312 | PubMed |
| 4 | 12,939,737 | Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects. | Metabolism | 2003 | https://conductscience.org/library/papers/12939737 | PubMed |
| 5 | 11,157,348 | Probiotics: determinants of survival and growth in the gut. | Am J Clin Nutr | 2001 | https://conductscience.org/library/papers/11157348 | PubMed |
| 6 | 14,706,810 | The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. | Eur J Pharm Sci | 2004 | https://conductscience.org/library/papers/14706810 | PubMed |
| 7 | 17,200,703 | The role of gut hormones in glucose homeostasis. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17200703 | PubMed |
| 8 | 1,794,262 | The mode of action and clinical pharmacology of gliclazide: a review. | Diabetes Res Clin Pract | 1991 | https://conductscience.org/library/papers/1794262 | PubMed |
| 9 | 15,352,898 | Review article: antibiotics and probiotics in inflammatory bowel disease. | Aliment Pharmacol Ther | 2004 | https://conductscience.org/library/papers/15352898 | PubMed |
| 10 | 9,200,314 | Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. | Scand J Gastroenterol Suppl | 1997 | https://conductscience.org/library/papers/9200314 | PubMed |
| 11 | 12,675,685 | Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. | Cell Microbiol | 2003 | https://conductscience.org/library/papers/12675685 | PubMed |
| 12 | 15,529,516 | Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide. | Int J Clin Pract | 2004 | https://conductscience.org/library/papers/15529516 | PubMed |
| 13 | 8,732,950 | Scaling basic toxicokinetic parameters from rat to man. | Environ Health Perspect | 1996 | https://conductscience.org/library/papers/8732950 | PubMed |
| 14 | 15,200,348 | The role of sulphonylureas in the management of type 2 diabetes mellitus. | Drugs | 2004 | https://conductscience.org/library/papers/15200348 | PubMed |
| 15 | 11,073,816 | The effect of rifampin treatment on intestinal expression of human MRP transporters. | Am J Pathol | 2000 | https://conductscience.org/library/papers/11073816 | PubMed |
| 16 | 14,566,382 | Probiotics: Isolated bacteria strain or mixtures of different strains? Two different approaches in the use of probiotics as therapeutics. | Drugs Today (Barc) | 2003 | https://conductscience.org/library/papers/14566382 | PubMed |
| 17 | 401,727 | Drug interactions with oral sulphonylurea hypoglycaemic drugs. | Drugs | 1977 | https://conductscience.org/library/papers/401727 | PubMed |
| 18 | 15,111,555 | Glycemic treatment: Control of glycemia. | Diabetes Care | 2004 | https://conductscience.org/library/papers/15111555 | PubMed |
| 19 | 17,077,077 | Safety of probiotics. | Asia Pac J Clin Nutr | 2006 | https://conductscience.org/library/papers/17077077 | PubMed |
| 20 | 15,721,033 | Amendments to the theory underlying Ussing chamber data of chloride ion secretion after bacterial enterotoxin exposure. | J Theor Biol | 2005 | https://conductscience.org/library/papers/15721033 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,707,375 | Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome-drug-host triad. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42707375 | PubMed |
| 40,634,920 | Probiotic preserving extract supplementation as a novel attitude in managing diabetes mellitus. | BMC Complement Med Ther | 2025 | https://conductscience.org/library/papers/40634920 | PubMed |
| 38,789,535 | Computational prediction of new therapeutic effects of probiotics. | Sci Rep | 2024 | https://conductscience.org/library/papers/38789535 | PubMed |
| 35,203,519 | The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus. | Biomedicines | 2022 | https://conductscience.org/library/papers/35203519 | PubMed |
| 34,386,321 | The influence of the gut microbiota on the bioavailability of oral drugs. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/34386321 | PubMed |
| 34,103,897 | Cinnamaldehyde Improves Metabolic Functions in Streptozotocin-Induced Diabetic Mice by Regulating Gut Microbiota. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/34103897 | PubMed |
| 32,751,051 | Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32751051 | PubMed |
| 32,708,933 | Safety of Probiotics: Functional Fruit Beverages and Nutraceuticals. | Foods | 2020 | https://conductscience.org/library/papers/32708933 | PubMed |
| 32,382,021 | Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies. | Sci Rep | 2020 | https://conductscience.org/library/papers/32382021 | PubMed |
| 32,290,519 | Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32290519 | PubMed |
| 31,919,411 | Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study. | Sci Rep | 2020 | https://conductscience.org/library/papers/31919411 | PubMed |
| 31,719,879 | Influence of Biotechnological Processes, Speed of Formulation Flow and Cellular Concurrent Stream-Integration on Insulin Production from β-cells as a Result of Co-Encapsulation with a Highly Lipophilic Bile Acid. | Cell Mol Bioeng | 2018 | https://conductscience.org/library/papers/31719879 | PubMed |
| 31,607,925 | Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31607925 | PubMed |
| 30,931,309 | Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity. | Front Nutr | 2019 | https://conductscience.org/library/papers/30931309 | PubMed |
| 30,513,975 | Biological Activities of Lactose-Based Prebiotics and Symbiosis with Probiotics on Controlling Osteoporosis, Blood-Lipid and Glucose Levels. | Medicina (Kaunas) | 2018 | https://conductscience.org/library/papers/30513975 | PubMed |
| 30,319,399 | Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30319399 | PubMed |
| 29,039,071 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics. | Eur J Drug Metab Pharmacokinet | 2018 | https://conductscience.org/library/papers/29039071 | PubMed |
| 28,547,295 | High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect. | Eur J Drug Metab Pharmacokinet | 2017 | https://conductscience.org/library/papers/28547295 | PubMed |
| 27,499,689 | Heat-killed Lactobacillus Reuteri GMNL-263 Prevents Epididymal Fat Accumulation and Cardiac Injury in High-Calorie Diet-Fed Rats. | Int J Med Sci | 2016 | https://conductscience.org/library/papers/27499689 | PubMed |
| 26,797,809 | Effect of Lactobacillus casei on the Pharmacokinetics of Amiodarone in Male Wistar Rats. | Eur J Drug Metab Pharmacokinet | 2017 | https://conductscience.org/library/papers/26797809 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5,243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| ABCC2 | 1,244 | PubTator's text mining | https://conductscience.org/library/genes/1244 | NCBI Gene |
| ABCC3 | 8,714 | PubTator's text mining | https://conductscience.org/library/genes/8714 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20157366
GET https://conductscience.org/api/papers/v1/20157366/references?page=2